Report from Thailand - The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness. - BioPharm International

ADVERTISEMENT

Report from Thailand
The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness.


BioPharm International
Volume 26, Issue 4, pp. 8-9

IMPORTANT FACTS

  • Under Thailand's first National Biotechnology Policy Framework (2004 to 2009), 90 new companies were formed, bringing the number of biotech companies to an estimated total of 170.
  • Thailand has succeeded in producing the world's first commercial biosensor for avian influenza. Currently, it is in the process of producing its first indigenous drug to treat malaria. If successful, it will be a breakthrough development that puts Thailand on the world map.
  • Thailand is regarded as a prime "pharmerging market" due to the potential of its biotech sector. The large population and academic/healthcare infrastructure make the country an ideal provider of clinical trials.

—Jane Wan is a freelance writer based in Singapore.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Lilly to Acquire Novartis Animal Health
April 22, 2014
Novartis and GSK Trade Assets
April 22, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
EMA Warns of Falsified Herceptin Vials
April 16, 2014
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
Author Guidelines
Source: BioPharm International,
Click here